MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 30 filers reported holding MILESTONE PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,165,531 | +28.8% | 126,826 | -13.8% | 0.10% | +57.8% |
| Q2 2022 | $905,065 | -4.2% | 147,165 | 0.0% | 0.06% | -12.3% |
| Q1 2022 | $944,799 | -2.0% | 147,165 | 0.0% | 0.07% | +17.7% |
| Q4 2021 | $963,931 | +48.6% | 147,165 | +29.6% | 0.06% | +37.8% |
| Q3 2021 | $648,639 | – | 113,597 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 2,530,585 | $16,955,000 | 0.73% |
| Ikarian Capital, LLC | 1,836,545 | $12,305,000 | 0.54% |
| Boxer Capital, LLC | 2,477,194 | $16,597,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,911,000 | 0.48% |
| RA Capital Management | 2,327,714 | $15,596,000 | 0.22% |
| Orbimed Advisors | 2,493,109 | $16,704,000 | 0.15% |
| PURA VIDA INVESTMENTS, LLC | 450,000 | $3,015,000 | 0.11% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,704,000 | 0.08% |
| Anson Funds Management LP | 50,113 | $336,000 | 0.07% |
| Tekla Capital Management LLC | 253,610 | $1,699,000 | 0.06% |